NHS Framework for the North of England, Branded Medicine

Published facts

What the notice says

Buyer

NHS England

Published status

complete

Latest release reference

521ac6ee-777d-4ac4-8c5c-88045d5101fd-670252

CPV codes

Common Procurement Vocabulary (CPV) codes: 33600000

Published tags

award

Latest record Bidwake loaded from this source

27 Aug 2026

Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Open the official Contracts Finder notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

1. Award notice observed

   8 Aug 2023

   Latest variant observed by Bidwake on 20 Aug 2026.

   Open this official Contracts Finder notice

   Record references

   Release reference

   521ac6ee-777d-4ac4-8c5c-88045d5101fd-670252

   Published tags

   award

Awards and suppliers

Published award and contract facts

• NHS Framework for the North of England, Branded Medicine

  Buyer: NHS EnglandSupplier: Accord-UK Ltd

  End date in notice

  29 Feb 2024

  Value shown in notice

  £238,913,892Whole award value; not assigned to one supplier

  Official source

  Open the official Contracts Finder notice for NHS Framework for the North of England, Branded Medicine

  About this figure

  • This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.

  View record references

  Source

  Contracts Finder

  Award or lot reference

  ocds-b5fd17-8f156716-6a74-476b-ac41-29b32bb73599-3

• NHS Framework for the North of England, Branded Medicine

  Buyer: NHS EnglandSupplier: Amgen Ltd

  End date in notice

Related evidence

Published terms and linked processes

No recurrence, renewal or options wording appears in these notices.

No exact source-published process relationship was found.